Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and OpportunitiesFRONTIERS IN MEDICINEIF32021-09-0910OAAI
Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory StudyPHARMACEUTICAL MEDICINEIF4.52021-07-2212OAAI
Consistency of a dialyzable leucocyte extract manufactured at GMP facilities by nuclear magnetic resonance spectroscopyJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12021-03-013PREAI
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal AnalysisANALYTICAL CHEMISTRYIF6.72019-10-3011PREAI
Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch ReleaseMOLECULESIF4.62019-09-205OAAI
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality AttributesJOURNAL OF FOOD SCIENCEIF3.42019-02-1522OAAI
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detectionJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12018-06-014OAAI
Response to: Comment on New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar EtanerceptJOURNAL OF IMMUNOLOGY RESEARCHIF3.62018-01-010OAAI
Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetateJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12017-01-015PREAI
New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar EtanerceptJOURNAL OF IMMUNOLOGY RESEARCHIF3.62016-01-0113OAAI
Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory ActivityJOURNAL OF IMMUNOLOGY RESEARCHIF3.62015-01-0124OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向